Cal­cu­lat­ing health­care's re­al costs

2 months ago
Health Tech

Ax­some re­ports Phase 3 win for Sunosi in adults with AD­HD, with a high-dose caveat

2 months ago
R&D
Pharma

GSK scores FDA ap­proval for an­tibi­ot­ic to treat un­com­pli­cat­ed UTIs

2 months ago
Pharma
FDA+

Ex­clu­sive: mR­NA start­up Turn Biotech­nolo­gies ac­quires Vesi­gen’s mi­crovesi­cle de­liv­ery tech

2 months ago
R&D

WuXi Bi­o­log­ics’ li­cens­ing deals help off­set Biose­cure threat in the US

2 months ago
Deals
China

Kezar toplines small Phase 2a dataset in au­toim­mune liv­er dis­ease

2 months ago
R&D

Cas­sa­va ends work on Alzheimer's drug; Alu­mis gets $40M up­front from Kak­en

2 months ago
News Briefing

Oph­thal­mol­o­gy start­up Char­ac­ter Bio­sciences gets $93M for ge­net­ics-based ap­proach

2 months ago
Financing
Startups

GSK to re­search whether shin­gles vac­cine can cut de­men­tia risk

2 months ago
R&D

An­oth­er im­munol­o­gy biotech emerges as Hill­star takes flight with $67M

2 months ago
Financing
Startups

Mer­ck strikes deal for heart drug, worth up to $2B, with Chi­na’s Hen­grui

2 months ago
Deals
China

Trump taps act­ing CDC chief Su­san Monarez for per­ma­nent role

2 months ago
People
FDA+

Three ma­jor ques­tions on phar­ma tar­iffs Trump claims are on the way

2 months ago
Pharma
Manufacturing

Ab­b­Vie files trade se­crets suit against ADC com­peti­tor

2 months ago
Pharma
Law

FDA's bi­o­log­ics chief stress­es need for vac­cine trans­mis­sion da­ta de­spite high costs to gen­er­ate

2 months ago
R&D
FDA+

Two biotechs fail to beat or match Re­gen­eron's Eylea in key tri­als

2 months ago
R&D

Sur­rozen rais­es $175M, to fo­cus on oph­thal­mol­o­gy; CBC Group has a new $1B fund

2 months ago
News Briefing

No­vo Nordisk pays $200M up­front for Chi­na-based biotech’s triple-G obe­si­ty shot

2 months ago
Deals
R&D

Bio­gen plans to open new head­quar­ters in Boston area in 2028

2 months ago
R&D

Tem­pero Bio, led by ex-No­var­tis ex­ecs, gets $70M to re­duce sub­stance use dis­or­ders

2 months ago
Financing
Startups

23andMe files for bank­rupt­cy, CEO Wo­j­ci­c­ki steps down

2 months ago
Financing
Health Tech

Bel­gian biotech Au­gus­tine gets $85M for neu­ro and car­diometa­bol­ic pills

2 months ago
Financing
Startups

Teenag­er dies af­ter re­ceiv­ing Sarep­ta ther­a­py; Im­muno­vant gets Phase 3 win, but shifts fo­cus; Al­ny­lam’s big mo­ment; ...

2 months ago
Weekly

Liv­er can­cer drug com­bo gets sec­ond FDA re­jec­tion over man­u­fac­tur­ing is­sues

2 months ago
Pharma
FDA+
First page Previous page 24252627282930 Next page Last page
A service from the Financial Times